Clinical Trials for Lupus Nephritis Patients

Chris Comish avatar

by Chris Comish |

Share this article:

Share article via email

Lupus is a chronic, non-contagious and autoimmune disease that can affect and weaken any part of the patient’s body. Lupus affects people by attacking the patient’s immune system, and the immune system is what protects you from viruses, bacteria, and germs.

Interested in knowing what the symptoms of lupus are? Read more about it here.

Lupus nephritis is a form of lupus that attacks the kidneys and can cause kidney failure. This is what happened to celebrity Nick Cannon. In this video, shared by ImmuneTolerance, listen to Dr. Maria Dall’Era from the University of California, San Francisco, talk about lupus nephritis and CALIBRATE, a study for patients suffering from lupus nephritis.

As read in the video description, CALIBRATE “is a clinical research study testing the safety and efficacy of an investigational drug approach in lupus nephritis: treatment with rituximab  and cyclophosphamide followed by belimumab.” Watch the video to learn more about this study and how it can benefit lupus nephritis’ patients.

Here’s a list of 5 lupus treatments you should know about.

Lupus News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.